Ledger.Open graph →
SEC Form D · Amendment · filed September 23, 2020

Finch Therapeutics Group, Inc

Offering
$90.0M
Sold
$90.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOMERVILLE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (33)

Zain Kassam · Somerville, MAExecBenjamin Enerson · Somerville, MAExecChristopher A. Cosmides · Somerville, MADirectorMark Smith · Somerville, MAExec · DirectorJo A. Viney · Somerville, MADirectorChris Lange · Somerville, MADirectorAndrew Noh · Somerville, MAExecJeffery A. Smisek · Somervlle, MADirectorDomenic Ferrante · Somerville, MADirectorAndrew Mulderry · Somerville, MADirectorJames Burgess · Somerville, MAExecMichael Galgon · Seattle, WADirectorGabriel Haddad Silva · Grand Cayman, Cayman IslandsDirectorDavid T. Sinclair · Boston, MAExecSheryl Elsdon · Vancouver, British Columbia, CanadaDirectorLair G. Kennedy · Louisville, COExecCarter G. Mcnabb · Louisville, CODirectorShane Slominski · Minnetonka, MNDirectorBracken T. Darrell · Boston, MAExec · DirectorKerry Song · San Clemente, CAExecAlexander T. Edwards · Boston, MAExecAllison Harr · Seattle, WADirectorJackie N. Charlesworth · Hong Kong, Hong KongDirectorMatthew N. Whitehead · Hong Kong, Hong KongExec · DirectorMilton Berlinski · New York, NYDirectorPeter Aberg · New York, NYDirectorTodd Haskins · New York, NYExecMarc N. Puglia · PROVIDENCE, RIExecPatrick Dunn · PROVIDENCE, RIExecHarry W. Lengsfield · NEW YORK, NYExecRuoyu Wang · San Francisco, CADirectorLei Xu · San Francisco, CADirectorRichard G. Schultze · Plano, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗